Obesity-Associated Asthma Has a Dietary Source

Saturated fatty acids directly activated innate immune cells in the lung, leading to inflammatory responses.

Written byShelby Bradford, PhD
| 2 min read
Illustration of a transparent human torso with the respiratory tract and alveoli highlighted in light orange to indicate asthma.
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

People with obesity can experience obesity-associated asthma. Unlike asthma induced by allergens, obesity-associated asthma is characterized by inflammatory macrophages and monocytes and high levels of neutrophils in the lungs.1 The mechanisms underlying this immune cell activation in the lung and its contribution to obesity-associated asthma have not been well characterized.

A team led by David Hill, an immunologist at the University of Pennsylvania, sought to investigate this question further. “Prior to this study, many suspected that childhood obesity was causing this form of asthma. However, we were observing neutrophilic asthma in children who weren’t obese, which is why we suspected there might be another mechanism,” he said in a press release.

His team showed that specific lipids in a high-fat diet activated resident immune cells in the lungs of mice. These activated macrophages and monocytes led to an elevated inflammatory response in an asthma model.2 The findings, published in Science Translational Medicine, offer a path to new treatment options for people with obesity-associated asthma.

The researchers saw that feeding mice a high-fat diet for 12 weeks increased the population of inflammatory macrophages and monocytes in their lungs. These cells also had increased intracellular lipid accumulation, where the team observed an increased amount of saturated long-chain fatty acid. When they treated these cells or bone marrow derived macrophages with one of the highly abundant saturated fatty acids, stearic acid, they saw that this activated a key inflammatory complex, the inflammasome.

To confirm that these effects were independent of other obesity-related changes, the team fed a new set of mice a high-fat diet where the lipid component is predominantly stearic acid. After four weeks, the researchers showed that the diet activated macrophages and monocytes in the lungs similarly to the full high-fat diet.

Continue reading below...

Like this story? Sign up for FREE Immunology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

Next, the team developed an asthma model that replicated the inflammation seen in obesity-associated asthma by treating mice with a mixture of house dust mite extracts and lipopolysaccharide. Compared to mice fed a normal diet, those fed a diet with increased stearic acid experienced worsened airway inflammation and pulmonary function. The team showed that the activation of the inflammasome in lung resident monocytes and macrophages caused this aggravated immune response.

Finally, the researchers studied lung fluid from people with varying body mass indexes (BMIs). They saw that individuals with higher BMIs had more inflammatory monocytes with greater lipid content and evidence of inflammasome activation, and they saw that this further increased in people with asthma.

“While there are many risk factors and triggers that are associated with asthma, this study provides evidence about how specific dietary components are linked to a particularly difficult-to-treat form of asthma. These findings are encouraging because they provide new treatment strategies and suggest that targeted dietary modifications may help prevent this asthma type,” said Lisa Young, a physician scientist at the University of Pennsylvania and study coauthor.

Related Topics

Meet the Author

  • Shelby Bradford, PhD

    Shelby is an Assistant Editor at The Scientist. She earned her PhD in immunology and microbial pathogenesis from West Virginia University, where she studied neonatal responses to vaccination. She completed an AAAS Mass Media Fellowship at StateImpact Pennsylvania, and her writing has also appeared in Massive Science. Shelby participated in the 2023 flagship ComSciCon and volunteered with science outreach programs and Carnegie Science Center during graduate school. 

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies